This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Statin treatment and renal failure

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

A prospective open cohort study has examined and quantified the unintended risks and benefits of statins in a large representative primary care population over a six year period.

With respect to statin treatment and association with acute renal failure

  • risk of acute renal failure was increased in both men and women prescribed simvastatin, atorvastatin, and pravastatin and in women prescribed fluvastatin. The magnitudes of the adjusted hazard ratios were similar for each statin, ranging from 1.50 to 2.19, and direct comparisons showed no difference in risk by type of statin (P=0.91 in men, P=0.37 in women)
  • NNH for an additional case of acute renal failure over five years was 434 (284 to 783)

Reference:


Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page